ARRJF
Price
$3.07
Change
-$0.40 (-11.53%)
Updated
Nov 6 closing price
MAHLY
Price
$16.07
Change
+$0.48 (+3.08%)
Updated
Dec 16 closing price
Ad is loading...

ARRJF vs MAHLY

Header iconARRJF vs MAHLY Comparison
Open Charts ARRJF vs MAHLYBanner chart's image
Arjo AB
Price$3.07
Change-$0.40 (-11.53%)
Volume$6K
CapitalizationN/A
Medipal Holdings
Price$16.07
Change+$0.48 (+3.08%)
Volume$1.22K
CapitalizationN/A
ARRJF vs MAHLY Comparison Chart
Loading...
ARRJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ARRJF vs. MAHLY commentary
Dec 23, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ARRJF is a Hold and MAHLY is a Hold.

COMPARISON
Comparison
Dec 23, 2024
Stock price -- (ARRJF: $3.07 vs. MAHLY: $16.08)
Brand notoriety: ARRJF and MAHLY are both not notable
Both companies represent the Medical Distributors industry
Current volume relative to the 65-day Moving Average: ARRJF: 120% vs. MAHLY: 126%
Market capitalization -- ARRJF: $1.16B vs. MAHLY: $3.69B
ARRJF [@Medical Distributors] is valued at $1.16B. MAHLY’s [@Medical Distributors] market capitalization is $3.69B. The market cap for tickers in the [@Medical Distributors] industry ranges from $70.55B to $0. The average market capitalization across the [@Medical Distributors] industry is $9.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ARRJF’s FA Score shows that 1 FA rating(s) are green whileMAHLY’s FA Score has 0 green FA rating(s).

  • ARRJF’s FA Score: 1 green, 4 red.
  • MAHLY’s FA Score: 0 green, 5 red.
According to our system of comparison, MAHLY is a better buy in the long-term than ARRJF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ARRJF’s TA Score shows that 2 TA indicator(s) are bullish while MAHLY’s TA Score has 3 bullish TA indicator(s).

  • ARRJF’s TA Score: 2 bullish, 1 bearish.
  • MAHLY’s TA Score: 3 bullish, 2 bearish.
According to our system of comparison, both ARRJF and MAHLY are a good buy in the short-term.

Price Growth

ARRJF (@Medical Distributors) experienced а 0.00% price change this week, while MAHLY (@Medical Distributors) price change was +3.04% for the same time period.

The average weekly price growth across all stocks in the @Medical Distributors industry was +0.86%. For the same industry, the average monthly price growth was +2.51%, and the average quarterly price growth was +147.05%.

Industries' Descriptions

@Medical Distributors (+0.86% weekly)

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MAHLY($3.69B) has a higher market cap than ARRJF($1.16B). ARRJF has higher P/E ratio than MAHLY: ARRJF (33.78) vs MAHLY (13.48). MAHLY YTD gains are higher at: -0.740 vs. ARRJF (-19.843). MAHLY has higher annual earnings (EBITDA): 74B vs. ARRJF (1.84B). MAHLY has more cash in the bank: 252B vs. ARRJF (1.07B). ARRJF has less debt than MAHLY: ARRJF (1.2B) vs MAHLY (30B). MAHLY has higher revenues than ARRJF: MAHLY (3.35T) vs ARRJF (10.5B).
ARRJFMAHLYARRJF / MAHLY
Capitalization1.16B3.69B32%
EBITDA1.84B74B2%
Gain YTD-19.843-0.7402,681%
P/E Ratio33.7813.48251%
Revenue10.5B3.35T0%
Total Cash1.07B252B0%
Total Debt1.2B30B4%
FUNDAMENTALS RATINGS
ARRJF vs MAHLY: Fundamental Ratings
ARRJF
MAHLY
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
89
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
8039
PRICE GROWTH RATING
1..100
8155
P/E GROWTH RATING
1..100
9076
SEASONALITY SCORE
1..100
3911

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ARRJF's Valuation (29) in the null industry is somewhat better than the same rating for MAHLY (89). This means that ARRJF’s stock grew somewhat faster than MAHLY’s over the last 12 months.

ARRJF's Profit vs Risk Rating (100) in the null industry is in the same range as MAHLY (100). This means that ARRJF’s stock grew similarly to MAHLY’s over the last 12 months.

MAHLY's SMR Rating (39) in the null industry is somewhat better than the same rating for ARRJF (80). This means that MAHLY’s stock grew somewhat faster than ARRJF’s over the last 12 months.

MAHLY's Price Growth Rating (55) in the null industry is in the same range as ARRJF (81). This means that MAHLY’s stock grew similarly to ARRJF’s over the last 12 months.

MAHLY's P/E Growth Rating (76) in the null industry is in the same range as ARRJF (90). This means that MAHLY’s stock grew similarly to ARRJF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ARRJFMAHLY
RSI
ODDS (%)
N/A
Bullish Trend 4 days ago
28%
Stochastic
ODDS (%)
N/A
Bearish Trend 4 days ago
38%
Momentum
ODDS (%)
Bullish Trend 4 days ago
11%
Bullish Trend 4 days ago
28%
MACD
ODDS (%)
Bullish Trend 5 days ago
10%
Bullish Trend 4 days ago
25%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
18%
Bullish Trend 4 days ago
36%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
19%
Bullish Trend 4 days ago
35%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bearish Trend 4 days ago
34%
Bearish Trend 4 days ago
35%
View a ticker or compare two or three
Ad is loading...
ARRJF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MAHLY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JSVAX27.780.46
+1.68%
Janus Henderson Contrarian T
ICISX16.910.15
+0.89%
VY® Columbia Small Cap Value II I
FEVCX19.440.17
+0.88%
First Eagle US Value C
GCAEX6.100.05
+0.83%
Gabelli Equity Income A
EMILX15.600.05
+0.32%
Lord Abbett Emerging Markets Equity I

ARRJF and

Correlation & Price change

A.I.dvisor tells us that ARRJF and SHPMF have been poorly correlated (+8% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ARRJF and SHPMF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ARRJF
1D Price
Change %
ARRJF100%
N/A
SHPMF - ARRJF
8%
Poorly correlated
N/A
COSM - ARRJF
5%
Poorly correlated
-5.82%
MAHLY - ARRJF
2%
Poorly correlated
N/A
PDRX - ARRJF
0%
Poorly correlated
N/A
MEPDF - ARRJF
0%
Poorly correlated
N/A
More

MAHLY and

Correlation & Price change

A.I.dvisor tells us that MAHLY and ZYXI have been poorly correlated (+5% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MAHLY and ZYXI's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MAHLY
1D Price
Change %
MAHLY100%
N/A
ZYXI - MAHLY
5%
Poorly correlated
-1.79%
PDRX - MAHLY
2%
Poorly correlated
N/A
SHPMF - MAHLY
2%
Poorly correlated
N/A
ARRJF - MAHLY
2%
Poorly correlated
N/A
COSM - MAHLY
2%
Poorly correlated
-5.82%
More